TIS 0.00% 0.0¢ tissue therapies limited

referral to ema, page-56

  1. 3,639 Posts.
    lightbulb Created with Sketch. 306
    "BSI has further advised the Company that the review by MHRA will take up to 30 calendar" days"

    That was the 8/8...its now 28/8, surely we will at least get an update in the next 10 days???

    I am still hopeful (not confident) that this issue will be resolved inside the 30 days, and will be looking to top up this week if the opportunity arises.

    The product is still exactly the same, as is the market size and potential just in wound healing alone, not to mention the myriad of other potential uses (I have always thought beauty products has the most potential)...so its still game on IMO!
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.